IFx-Hu2.0 Access Program for Advanced Skin Cancers
Sponsor: TuHURA Biosciences, Inc.
ClinicalTrials ID:NCT04853602
This program offers access to the experimental treatment IFx-Hu2.0 for adults with advanced skin cancers, including stage III-IV melanoma, Merkel cell carcinoma, or cutaneous squamous cell carcinoma, who have no other treatment options left.
Patient Parameters
| Parameter | Options |
|---|
Program Overview
The IFx-Hu2.0 Expanded Access Program is designed to provide the experimental treatment IFx-Hu2.0 to adults aged 18 and older who have advanced skin cancers such as stage III-IV melanoma, advanced Merkel cell carcinoma, or advanced cutaneous squamous cell carcinoma. This program is intended for patients who have tried all other available treatments without success. To learn more about how to access this treatment, please contact the responsible party listed in the program details.
Eligibility Criteria
Inclusion Criteria
- To request more information use Responsible Party contact information provided in this record
Exclusion Criteria
- To request more information use Responsible Party contact information provided in this record
Get This Program In Your Inbox
Receive detailed information about this treatment opportunity to review with your healthcare provider.